Literature DB >> 9852568

Protein kinase A activity may kinetically upregulate the striatal transporter for dopamine.

M Batchelor1, J O Schenk.   

Abstract

The neuronal dopamine transporter (DAT) plays a key role in terminating dopaminergic chemical neurotransmission; thus, the study of the regulation of DAT activity is important in defining parameters relevant to the control of dopaminergic neurotransmission. Interpretation of the results from previous work of this laboratory suggests that occupation of presynaptic autoreceptors increases DAT activity. Second messenger signaling related to kinetic upregulation of DAT has not been examined previously. However, others have shown that protein kinase C activity may downregulate DAT activity, whereas protein kinase A has shown variable results. Herein it is shown that protein kinase A activity mediates the kinetic upregulation of DAT. Quinpirole increased DAT activity that was blocked by sulpiride and the protein kinase A selective inhibitor H-89. Brief incubations with forskolin and 8-bromo-cAMP (8-Br-cAMP) were found to stimulate striatal DAT activity by increasing the Vmax of transport without affecting the Km. Exposures >15 min had no effect. The 8-Br-cAMP-stimulated increases in DAT activity were blocked by pre-exposure to H-89. Thus, second messenger signaling via the cAMP cascade may mediate kinetic upregulation of DAT. Kinetic analyses of the results suggest that either insertion of DAT into the membrane or activation of pre-existing DAT within the membrane mediates the regulation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9852568      PMCID: PMC6793346     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  25 in total

1.  Repeated cocaine modifies the mechanism by which amphetamine releases dopamine.

Authors:  R C Pierce; P W Kalivas
Journal:  J Neurosci       Date:  1997-05-01       Impact factor: 6.167

2.  Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes.

Authors:  R A Vaughan; R A Huff; G R Uhl; M J Kuhar
Journal:  J Biol Chem       Date:  1997-06-13       Impact factor: 5.157

3.  D2 receptors may modulate the function of the striatal transporter for dopamine: kinetic evidence from studies in vitro and in vivo.

Authors:  S M Meiergerd; T A Patterson; J O Schenk
Journal:  J Neurochem       Date:  1993-08       Impact factor: 5.372

4.  Comparison of characteristics of dopamine uptake and mazindol binding in mouse striatum.

Authors:  I Zimányi; A Lajtha; M E Reith
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-12       Impact factor: 3.000

5.  Adenosine 3',5'-cyclic monophosphate enhances dopamine accumulation in rat hypothalamic cell culture containing dopaminergic neurons.

Authors:  K Kadowaki; K Hirota; K Koike; M Ohmichi; H Kiyama; A Miyake; O Tanizawa
Journal:  Neuroendocrinology       Date:  1990-09       Impact factor: 4.914

6.  Protein kinase C inhibitors block amphetamine-mediated dopamine release in rat striatal slices.

Authors:  L Kantor; M E Gnegy
Journal:  J Pharmacol Exp Ther       Date:  1998-02       Impact factor: 4.030

7.  Phorbol esters increase dopamine transporter phosphorylation and decrease transport Vmax.

Authors:  R A Huff; R A Vaughan; M J Kuhar; G R Uhl
Journal:  J Neurochem       Date:  1997-01       Impact factor: 5.372

8.  Protein kinase C activators decrease dopamine uptake into striatal synaptosomes.

Authors:  B J Copeland; V Vogelsberg; N H Neff; M Hadjiconstantinou
Journal:  J Pharmacol Exp Ther       Date:  1996-06       Impact factor: 4.030

9.  Dopamine and gamma-aminobutyric acid transporters: differential regulation by agents that promote phosphorylation.

Authors:  Y Tian; G Kapatos; J G Granneman; M J Bannon
Journal:  Neurosci Lett       Date:  1994-05-23       Impact factor: 3.046

10.  Striatal transporter for dopamine: catechol structure-activity studies and susceptibility to chemical modification.

Authors:  S M Meiergerd; J O Schenk
Journal:  J Neurochem       Date:  1994-03       Impact factor: 5.372

View more
  20 in total

1.  Amphetamine potency varies with dopamine uptake rate across striatal subregions.

Authors:  Cody A Siciliano; Erin S Calipari; Sara R Jones
Journal:  J Neurochem       Date:  2014-07-30       Impact factor: 5.372

2.  Characterization of extracellular dopamine clearance in the medial prefrontal cortex: role of monoamine uptake and monoamine oxidase inhibition.

Authors:  H K Wayment; J O Schenk; B A Sorg
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

3.  Dephosphorylation of human dopamine transporter at threonine 48 by protein phosphatase PP1/2A up-regulates transport velocity.

Authors:  Jae-Won Yang; Garret Larson; Lisa Konrad; Madhur Shetty; Marion Holy; Kathrin Jäntsch; Mirja Kastein; Seok Heo; Fatma Asli Erdem; Gert Lubec; Roxanne A Vaughan; Harald H Sitte; James D Foster
Journal:  J Biol Chem       Date:  2018-12-26       Impact factor: 5.157

4.  Phosphorylation of dopamine transporter serine 7 modulates cocaine analog binding.

Authors:  Amy E Moritz; James D Foster; Balachandra K Gorentla; Michelle S Mazei-Robison; Jae-Won Yang; Harald H Sitte; Randy D Blakely; Roxanne A Vaughan
Journal:  J Biol Chem       Date:  2012-11-16       Impact factor: 5.157

Review 5.  Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters.

Authors:  Daniel P Bermingham; Randy D Blakely
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

6.  A functional fast scan cyclic voltammetry assay to characterize dopamine D2 and D3 autoreceptors in the mouse striatum.

Authors:  Francis K Maina; Tiffany A Mathews
Journal:  ACS Chem Neurosci       Date:  2010-03-12       Impact factor: 4.418

7.  Amphetamine distorts stimulation-dependent dopamine overflow: effects on D2 autoreceptors, transporters, and synaptic vesicle stores.

Authors:  Y Schmitz; C J Lee; C Schmauss; F Gonon; D Sulzer
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

8.  Chronic methylphenidate treatment enhances striatal dopamine neurotransmission after experimental traumatic brain injury.

Authors:  Amy K Wagner; Laura L Drewencki; Xiangbai Chen; F Ryan Santos; Amina S Khan; Rashed Harun; Gonzalo E Torres; Adrian C Michael; C Edward Dixon
Journal:  J Neurochem       Date:  2008-12-10       Impact factor: 5.372

9.  Altered dopamine release and uptake kinetics in mice lacking D2 receptors.

Authors:  Yvonne Schmitz; Claudia Schmauss; David Sulzer
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

Review 10.  Parkinson's disease: is the initial treatment established?

Authors:  J Eric Ahlskog
Journal:  Curr Neurol Neurosci Rep       Date:  2003-07       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.